EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

The objectives have been to establish evidence‐based guidelines and identify controversies regarding the management of patients with brain metastases. The collection of scientific data was obtained by consulting the Cochrane Library, bibliographic databases, overview papers and previous guidelines from scientific societies and organizations. A tissue diagnosis is necessary when the primary tumor is unknown or the aspect on computed tomography/magnetic resonance imaging is atypical. Dexamethasone is the corticosteroid of choice for cerebral edema. Anticonvulsants should not be prescribed prophylactically. Surgery should be considered in patients with up to three brain metastases, being effective in prolonging survival when the systemic disease is absent/controlled and the performance status is high. Stereotactic radiosurgery should be considered in patients with metastases of 3–3.5 cm of maximum diameter. Whole‐brain radiotherapy (WBRT) after surgery or radiosurgery is debated: in case of absent/controlled systemic cancer and Karnofsky Performance score of 70 or more, one can either withhold initial WBRT or deliver early WBRT with conventional fractionation to avoid late neurotoxicity. WBRT alone is the treatment of choice for patients with single or multiple brain metastases not amenable to surgery or radiosurgery. Chemotherapy may be the initial treatment for patients with brain metastases from chemosensitive tumors.

[1]  R. Gelber,et al.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.

[2]  M. Walker.  Oncology of the Nervous System , 2011, Cancer Treatment and Research.

[3]  L. Deangelis,et al.  Radiation‐induced dementia in patients cured of brain metastases , 1989, Neurology.

[4]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[5]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[6]  W. van Putten,et al.  Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors , 1994, Neurology.

[7]  A. Twijnstra,et al.  Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated? , 1996, Journal of neurology, neurosurgery, and psychiatry.

[8]  G. Duncan,et al.  A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis , 1996, Cancer.

[9]  E. Beuls,et al.  Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. , 1996, Seizure.

[10]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[11]  F. Lohr,et al.  Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Richard J. Kryscio,et al.  Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain , 1998 .

[13]  K. Wallner,et al.  Radiographic findings and morbidity in patients treated with stereotactic radiosurgery. , 1998, International journal of radiation oncology, biology, physics.

[14]  G. Sze,et al.  Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. , 1998, AJNR. American journal of neuroradiology.

[15]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[16]  K. Kelly,et al.  Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? , 1998, Lung cancer.

[17]  T. Hastie,et al.  Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis , 1999, Annals of Internal Medicine.

[18]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[19]  W. Shabana,et al.  Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. , 1999, AJNR. American journal of neuroradiology.

[20]  M. Gould,et al.  Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. , 1999, Annals of internal medicine.

[21]  P. Wen,et al.  Management of brain metastases. , 1999, Oncology.

[22]  L. Recht,et al.  Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors , 2000, Neurology.

[23]  J. Michalski,et al.  Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. , 2000, International journal of radiation oncology, biology, physics.

[24]  L Souhami,et al.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. , 2000, International journal of radiation oncology, biology, physics.

[25]  L. Thiberville,et al.  Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  P. Hoskin,et al.  Radiotherapy for brain metastases. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  R. Soffietti,et al.  Brain metastases from unknown primary tumour , 2001, Journal of Neurology.

[28]  M. Hartmann,et al.  Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. , 2001, AJNR. American journal of neuroradiology.

[29]  G. Barnett,et al.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery , 2001, International journal of cancer.

[30]  D. Antonadou,et al.  Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Mehta,et al.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. , 2002, International journal of radiation oncology, biology, physics.

[32]  M. Kosteljanetz,et al.  Detection of unknown primary tumours in patients with cerebral metastases using whole‐body 18F‐flouorodeoxyglucose positron emission tomography , 2002, European journal of neurology.

[33]  M. Prins,et al.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.

[34]  W. Curran,et al.  Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Levine,et al.  Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer☆ , 2003 .

[36]  E. Shaw,et al.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Armin Thron,et al.  Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases , 2004, Journal of Neuro-Oncology.

[38]  R. Soffietti,et al.  Radiotherapy and chemotherapy of brain metastases , 2005, Journal of Neuro-Oncology.

[39]  M. Brainin,et al.  Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004 * , 2004, European journal of neurology.

[40]  W. Curran,et al.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[42]  E. Shaw,et al.  Interim results of a Phase II study of resection and GliaSite brachytherapy for a single brain metastasis , 2004 .

[43]  T. Mikkelsen,et al.  Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation Necrosis , 2004, Neurosurgery.

[44]  P. Brown,et al.  Properly Selected Patients with Multiple Brain Metastases May Benefit from Aggressive Treatment of their Intracranial Disease , 2004, Journal of Neuro-Oncology.

[45]  F. Cappuzzo,et al.  Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  S. Tejwani,et al.  Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy. , 2004, Neuro-oncology.

[47]  R. Warnick,et al.  Stereotactic Radiosurgery for Patients with Solid Brain Metastases: Current Status , 2004, Journal of Neuro-Oncology.

[48]  Mark D. Johnson,et al.  Surgical Resection for Patients with Solid Brain Metastases: Current Status , 2004, Journal of Neuro-Oncology.

[49]  N. Viñolas,et al.  Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. , 2005, International journal of radiation oncology, biology, physics.